Analystreport

Acer Therapeutics Inc (NASDAQ: ACER) had its price target lowered by analysts at Roth Capital from $66.00 to $9.00.

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations